Ofloxacin + Ornidazole + Terbinafine Hydrochloride + Clobetasol PropionateThird Party Manufacturing in India

Ofloxacin + Ornidazole + Terbinafine Hydrochloride + Clobetasol Propionate cream works through a synergistic quad-action approach to address mixed cutaneous infections that present with bacterial, fungal, and inflammatory elements. Each active ingredient targets a specific pathophysiology. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV enzymes, halting bacterial replication and causing bacterial cell death. Ornidazole, a nitroimidazole derivative, undergoes intracellular reduction to form reactive intermediate radicals that damage microbial DNA, providing broad-spectrum coverage against anaerobic bacteria and protozoa.

Terbinafine Hydrochloride, an allylamine antifungal, selectively inhibits the fungal enzyme squalene epoxidase in the cell membrane. This block disrupts ergosterol biosynthesis and causes toxic squalene accumulation, leading to fungal cell death. Simultaneously, Clobetasol Propionate, a high-potency corticosteroid, binds to intracellular glucocorticoid receptors to stimulate anti-inflammatory proteins. This suppresses phospholipase A2 activity and inhibits the production of prostaglandins and leukotrienes, rapidly reducing swelling, redness, and itching.

By combining these four mechanisms, the cream effectively sterilizes the infection site from diverse pathogens while providing immediate relief from severe inflammation and pruritus. This makes the cream highly effective for managing severe, uncharacterized, or multi-pathogen dermatological conditions, preventing complications and ensuring faster skin barrier recovery.

Therapeutic Uses

Ofloxacin + Ornidazole + Terbinafine Hydrochloride + Clobetasol Propionate cream is indicated for the treatment of mixed or complicated skin infections where inflammation is prominent. Specific indications include:

• Mixed Skin Infections: Treats lesions co-infected with bacteria (Gram-positive/Gram-negative) and fungi or yeasts.
• Severe Inflammatory Dermatosis: Manages eczema, psoriasis, or contact dermatitis complicated by secondary bacterial or fungal infections.
• Infected Tinea Infections: Resolves severe ringworm, jock itch, or athlete's foot accompanied by swelling, bacterial contamination, and intense itching.
• Intertrigo and Intertriginous Infections: Treats red, macerated skin rashes in skin folds where sweat creates a breeding ground for mixed pathogens.

Why Manufacturers Choose Ofloxacin + Ornidazole + Terbinafine Hydrochloride + Clobetasol Propionate

This quad-action cream is one of the highest-volume prescription products in the Indian dermatology market. Because patients frequently present with mixed dermatological infections that are difficult to diagnose without laboratory cultures, physicians heavily rely on broad-spectrum combinations to ensure clinical success.

For third party manufacturing in India, this formulation is highly sought after by PCD franchise companies and distributors due to its high market turnover and strong brand loyalty. The combination requires precise manufacturing controls to ensure the physical stability of multiple active compounds in a single cream base. By manufacturing this product, companies can offer a highly effective, fast-acting solution that dominates the commercial outpatient market, making it an essential component of any competitive dermatological portfolio.